ArticleBMJ open2013
Pharmacist intervention for glycaemic control in the community (the RxING study).
Article in BMJ open, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT01335763 (Pharmacist Intervention for Glycemic Control in The Community), which is not on this map. Cited by 48 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Pharmacist Intervention for Glycemic Control in The Community (The RxING Study)
Who cites it
48 citing papers in PubMed, 3 syntheses or guidelines pooled it, 99 citations in OpenAlex.
- A systematic review of the role of community pharmacists in the prevention and control of cardiovascular diseases: the perceptions of patients.Systematic reviews · 2023Pooled it
- Impact of point-of-care tests in community pharmacies: a systematic review and meta-analysis.BMJ open · 2020Pooled it
- Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care.The Cochrane database of systematic reviews · 2016Pooled it
- Trial
- Implementation of Pharmacist Case-Finding and Care Pathway Intervention for Vascular Prevention (PRCJC open · 2025Article
- Hypertension care: the knowledge and attitudes of the community pharmacists.Journal of pharmaceutical policy and practice · 2025Article
- Exploring the Role of Clinical Pharmacists in the Correctional Health Care Setting: A Narrative Review.The Canadian journal of hospital pharmacy · 2025Review
- Managing common ambulatory conditions: Exploring clinical decision making performance between pharmacists and family physicians.Exploratory research in clinical and social pharmacy · 2023Article
- Development and Implementation of Workshops to Optimize the Delivery of Vaccination Services in Community Pharmacies: Thinking beyond COVID-19.Pharmacy (Basel, Switzerland) · 2023Article
- Development, Feasibility, Impact and Acceptability of a Community Pharmacy-Based Diabetes Care Plan in a Low-Middle-Income Country.Pharmacy (Basel, Switzerland) · 2023Article
- "Why Didn't They Teach Us This?" A Qualitative Investigation of Pharmacist Stakeholder Perspectives of Business Management for Community Pharmacists.Pharmacy (Basel, Switzerland) · 2023Article
- Effects of a Computerized Prescriber Order Entry System on Pharmacist Prescribing.The Canadian journal of hospital pharmacy · 2023Article
- Pharmacist Prescribing at Inpatient Discharge in Alberta.The Canadian journal of hospital pharmacy · 2023Article
- Community Pharmacists' Views on the Early Stages of Implementation of a National Pilot Independent Prescribing Service in Wales: A Qualitative Study.Integrated pharmacy research & practice · 2023Article
- The views and experiences of people with type 2 diabetes being cared for by their community pharmacist: a cross-sectional patient survey.Journal of diabetes and metabolic disorders · 2022Article
- Evaluation of Point-of-Care Testing in Pharmacy to Inform Policy Writing by the New Brunswick College of Pharmacists.Pharmacy (Basel, Switzerland) · 2022Article
- Article
- Problems in Coordinating and Accessing Primary Care for Attached and Unattached Patients Exacerbated During the COVID-19 Pandemic Year (the PUPPY Study): Protocol for a Longitudinal Mixed Methods Study.JMIR research protocols · 2021Article
- Perceptions of Independent Pharmacist Prescribing among Health Authority- and Community-Based Pharmacists in Northern British Columbia.Pharmacy (Basel, Switzerland) · 2021Article
- Achieving Influenza Vaccine Uptake Target in Canada via a Pharmacy-Led Telephone Discussion during the 2019-2020 Season.Vaccines · 2021Article
Corrections and comments
- Erratum issuedCorrection.2013
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo determine the effect of a community pharmacist prescribing intervention on glycaemic control in patients with poorly controlled type 2 diabetes.
designPragmatic, before-after design.
setting12 community pharmacies in Alberta, Canada.
participantsType 2 diabetes receiving oral hypoglycaemic medications and with glycated haemoglobin (HbA1c) of 7.5-11%.
interventionPharmacists systematically identified potential candidates by inviting patients with type 2 diabetes to test their HbA1c using validated point-of-care technology. Pharmacists prescribed 10 units of insulin glargine at bedtime, adjusted by increments of 1 unit daily to achieve a morning fasting glucose of ≤5.5 mmol/L. The patients were followed up at 2, 4, 8, 14, 20 and 26 weeks. PRIMARY OUTCOME: Change in HbA1c from baseline to week 26. SECONDARY OUTCOMES: Proportion of patients achieving target HbA1c, changes in oral hypoglycaemic agents, quality of life and patient satisfaction, persistence on insulin glargine, number of insulin dosage adjustments per patient and number of hypoglycaemic episodes.
resultsWe screened 365 patients of whom 111 were eligible. Of those, 100 (90%) were enrolled in the study; all 11 patients who did not consent refused to use insulin. Average age was 64 years (SD 10.4), while average diabetes duration was 10.2 years (SD 7). HbA1c was reduced from 9.1% (SD 1) at baseline to 7.3% (SD 0.9); a change of 1.8% (95% CI 1.4 to 2, p<0.001). Fasting plasma glucose was reduced from 11 (SD 3.3) to 6.9 mmol/L (SD 1.8); a change of 4.1 mmol/L (95% CI of 3.3 to 5, p=0.007). Fifty-one per cent of the patients achieved the target HbA1c of ≤7% at the end of the study.
conclusionsThis is the first completed study of independent prescribing by pharmacists. Our results showed similar improvements in glycaemic control as previous physician-led studies. RxING provides further evidence for the benefit of pharmacist care in diabetes.
trial registrationclinicaltrials.gov; Identifier: NCT01335763.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.